Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults
Cognitive Symptoms of Post–COVID-19 Condition and Daily Functioning
COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial
Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron
High-Dose Steroids for Nonresolving Acute Respiratory Distress Syndrome in Critically Ill COVID-19 Patients Treated With Dexamethasone: A Multicenter Cohort Study*
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.
Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19
Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
Mild or Moderate Covid-19
Severe Covid-19
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants
Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland
Age Moderates the Effect of Obesity on Mortality Risk in Critically Ill Patients With COVID-19: A Nationwide Observational Cohort Study*
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial
High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial
Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study
Dexamethasone in Hospitalized Patients with Covid-19
COVID-19 Rapid Antigen Tests With Self-Collected vs Health Care Worker–Collected Nasal and Throat Swab Specimens: A Randomized Clinical Trial
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection
Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients
Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States
Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19
VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19
High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trial
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Safety, tolerability, and pharmacokinetics of VV116, an oral nucleoside analog against SARS-CoV-2, in Chinese healthy subjects
An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants
Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

 Sofia; Yates
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial
Remdesivir for the Treatment of Covid-19 — Final Report
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19
Simvastatin in Critically Ill Patients with Covid-19
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
The outcome of using intravenous immunoglobulin (IVIG) in critically ill COVID-19 patients’: a retrospective, multi-centric cohort study
Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Excess All-Cause Mortality in China After Ending the Zero COVID Policy
Mortality for Time-Sensitive Conditions at Urban vs Rural Hospitals During the COVID-19 Pandemic
Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial
Influence of Preoperative COVID‐19 Vaccination on Outcomes After Coronary Artery Bypass Grafting—A Propensity Score–Matched Analysis
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial
